Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia (Q34196506)

31 July 2017

1 reference

title

Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia (English)

1 reference

31 July 2017

0 references

0 references

0 references

Vishnudutt Purohit

1

1 reference

31 July 2017

Rao Rapaka

series ordinal

2

1 reference

31 July 2017

David Shurtleff

series ordinal

3

1 reference

31 July 2017

publication date

1 July 2011

1 reference

31 July 2017

published in

Molecular Neurobiology

1 reference

31 July 2017

volume

44

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

102-110

1 reference

The Neuropathology of HIV/AIDS.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Anti-HIV drug distribution to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

HIV-associated brain pathology in the United Kingdom: an epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Acceleration of HIV dementia with methamphetamine and cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Neuroimmunity, drugs of abuse, and neuroAIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Cocaine increases stimulated dopamine release more in periadolescent than adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Smoking-induced change in intrasynaptic dopamine concentration: Effect of treatment for Tobacco Dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Severe subcortical degeneration in macaques infected with neurovirulent simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Cerebrospinal fluid catecholamine metabolites in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Dopamine deficits and regulation of the cAMP second messenger system in brains of simian immunodeficiency virus-infected rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Dopamine stimulates expression of the human immunodeficiency virus type 1 via NF-kappaB in cells of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Dopamine activates HIV in chronically infected T lymphoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Methamphetamine modulates DC-SIGN expression by mature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Methamphetamine enhances HIV infection of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Chicken ovalbumin upstream promoter transcription factor, a transcriptional activator of HIV-1 gene expression in human brain cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

In vivo microdialysis in awake, freely moving rats demonstrates HIV-1 Tat-induced alterations in dopamine transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Decreased brain dopaminergic transporters in HIV-associated dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Cocaine receptors on dopamine transporters are related to self-administration of cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Neurotransmitter transporters: recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Effects of apolipoprotein E on the human immunodeficiency virus protein Tat in neuronal cultures and synaptosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Dopaminergic neurotoxicity of HIV-1 gp120: reactive oxygen species as signaling intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Neurotoxicity of HIV-1 Tat protein: involvement of D1 dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8195-Z

Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs

21 January 2018

1 reference

12 December 2020

Methamphetamine rapidly decreases vesicular dopamine uptake

1 reference

12 December 2020

Nigral degeneration in acquired immune deficiency syndrome (AIDS)

1 reference

12 December 2020

Rapid and reversible effects of methamphetamine on dopamine transporters

1 reference

12 December 2020

HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations

1 reference

12 December 2020

HIV-associated neurocognitive disease continues in the antiretroviral era.

1 reference

12 December 2020

Effects of Selegiline in a retroviral rat model for neurodegenerative disease

1 reference

12 December 2020

Cerebrospinal fluid dopamine in HIV-1 infection

1 reference

12 December 2020

Changes to AIDS dementia complex in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Marijuana use and cognitive function in HIV-infected people

1 reference

12 December 2020

Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging

1 reference

12 December 2020

Neuronal damage of the substantia nigra in HIV-1 infected brains

1 reference

12 December 2020

Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use.

1 reference

12 December 2020

Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia

1 reference

12 December 2020

1 reference

12 December 2020

CREB and COUP-TF mediate transcriptional activation of the human immunodeficiency virus type 1 genome in Jurkat T cells in response to cyclic AMP and dopamine

1 reference

12 December 2020

Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones

1 reference

12 December 2020

Regional brain atrophy in HIV-1 infection: association with specific neuropsychological test performance

1 reference

12 December 2020

Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants

1 reference

12 December 2020

Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS.

1 reference

12 December 2020

10.1007/S12035-011-8195-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1006419397

0 references

1 reference